These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25618270)

  • 1. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
    Kin Tekce B; Tekce H; Aktas G; Sit M
    Clin Invest Med; 2014 Dec; 37(6):E377-83. PubMed ID: 25618270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
    Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
    Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus.
    Boronat M; García-Cantón C; Quevedo V; Lorenzo DL; López-Ríos L; Batista F; Riaño M; Saavedra P; Checa MD
    Ren Fail; 2014 Mar; 36(2):166-70. PubMed ID: 24059817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
    Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
    Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
    Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
    Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
    Jayachandran I; Sundararajan S; Paramasivam P; Venkatesan B; Subramanian SC; Balasubramanyam M; Mohan V; Manickam N
    Clin Biochem; 2017 Oct; 50(15):835-842. PubMed ID: 28495185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
    von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
    Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.
    Kobayashi K; Toyoda M; Kimura M; Hatori N; Furuki T; Sakai H; Takihata M; Umezono T; Ito S; Suzuki D; Takeda H; Kanamori A; Degawa H; Yamamoto H; Machimura H; Mokubo A; Chin K; Obana M; Hishiki T; Aoyama K; Nakajima S; Umezawa S; Shimura H; Aoyama T; Sato K; Miyakawa M
    Diab Vasc Dis Res; 2019 Jan; 16(1):103-107. PubMed ID: 30284913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.